BRP-Kendal Lakes

Miami, Florida 33175

1 studies enrolling now · 1 studies all time

What they study most

Amyloid, Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies

Studies at this site

• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) — Recruiting now